Skip to content
Biodatica
Start free

Pennington Biomedical Research Center

Baton Rouge, Louisiana

OncologyPhase II
Sign in to watch

What changed

Study registered, no phase assigned: CanCan Body Composition Study

6mo agoTrial registeredDec 26, 2025Source filing (opens the source filing in a new tab)

Momentum

62no change

Momentum 62 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    Study registered

    Oct 15, 2025

    Healthy Participants, Young Healthy Adults, Elderly (People Aged 65 or More) · RECRUITING · sponsor: Pennington Biomedical Research Center · CanCan Body Composition Study

    ClinicalTrials.gov · NCT07305753 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Jan 3, 2024

    Lung Cancer · ACTIVE_NOT_RECRUITING · sponsor: Pennington Biomedical Research Center · The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia

    ClinicalTrials.gov · NCT05919147 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources